Mesothelin, a novel immunotherapy target for triple negative breast cancer.
Tchou J, Wang LC, Selven B, Zhang H, Conejo-Garcia J, Borghaei H, Kalos M, Vondeheide RH, Albelda SM, June CH, Zhang PJ.
Tchou J, et al. Among authors: june ch.
Breast Cancer Res Treat. 2012 Jun;133(2):799-804. doi: 10.1007/s10549-012-2018-4. Epub 2012 Mar 15.
Breast Cancer Res Treat. 2012.
PMID: 22418702
Free PMC article.